Loading...
XSHE
000989
Market cap1.11bUSD
Dec 05, Last price  
9.26CNY
1D
0.98%
1Q
-13.46%
Jan 2017
-57.35%
IPO
-17.35%
Name

Jiuzhitang Co Ltd

Chart & Performance

D1W1MN
XSHE:000989 chart
P/E
36.25
P/S
3.30
EPS
0.26
Div Yield, %
4.32%
Shrs. gr., 5y
0.24%
Rev. gr., 5y
-5.72%
Revenues
2.37b
-18.77%
1,050,301,465946,530,7891,024,108,0141,101,092,5951,109,212,0051,122,389,7521,149,805,5631,042,414,9781,211,844,1401,405,350,432871,512,6802,673,798,0433,797,212,5933,162,109,0033,183,694,7893,559,540,9633,784,155,2363,033,265,8592,919,332,6282,371,372,833
Net income
216m
-27.31%
23,569,09640,306,819127,814,993199,893,946148,315,410162,691,134201,779,214111,562,163224,830,507245,740,572471,031,522651,809,785712,254,464336,479,563192,146,815272,309,874270,696,505357,985,434297,411,075216,202,223
CFO
199m
+63.89%
58,075,253135,961,08381,447,770131,212,474220,921,862185,789,943139,721,17387,775,86528,454,244118,592,670339,026,372612,378,390151,996,083425,861,442851,290,910609,555,035365,912,082499,132,759121,397,805198,958,495
Dividend
May 28, 20240.4 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria for cardiovascular and cerebrovascular disease; Guizhi Fuling pills, Buxue Shengru granules, and hemostasis and analgesia products for gynecological disease; Schicon for respiratory disease; and Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products for digestive disease. It also provides non-prescription drugs for treating nourishing QI and blood, cardiovascular and cerebrovascular, urinary system, pediatric, gynecological, skeletal muscle, respiratory, dermatology, nervous system, ENT, digestive system, and tumor diseases. Jiuzhitang Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.
IPO date
Jun 28, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT